CVE-2026-24216: NVIDIA BioNeMo Framework · Deserialization of Untrusted Data
Affects NVIDIA BioNeMo FrameworkSource CVE Database V5
Not known to be exploited · CVSS 7.8 High : upgrade to commit dfd83a7 in Main soon.
Data as of 21 Nov 2026, 17:35 UTC
- EPSS
- 0.2% chance of exploitation in 30 days – higher than 21% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
- Patch
- Available – fixed in commit dfd83a7 in Main
CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:HExploitation evidence
Disclosed: evidence found.
CVE published 20 May 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 21 Nov 2026.
What to do
Upgrade NVIDIA BioNeMo Framework to commit dfd83a7 in Main.
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| NVIDIABioNeMo Framework | Affected
| Fixed in
|
AI-suggested
If you cannot patch yet, users should limit local access to trusted users and avoid processing untrusted serialized data with the BioNeMo Framework.
Description
CVE-2026-24216 is a high-severity vulnerability in the NVIDIA BioNeMo Framework for Linux involving deserialization of untrusted data. Exploitation could allow an attacker to execute code, cause denial of service, disclose information, or tamper with data. The vulnerability requires local access with low complexity and user interaction.